{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T08:24:56Z","timestamp":1707553496731},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1476-511x-13-105","type":"journal-article","created":{"date-parts":[[2014,6,28]],"date-time":"2014-06-28T23:01:03Z","timestamp":1403996463000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical application of elevated platelet-activating factor acetylhydrolase in patients with hepatitis B"],"prefix":"10.1186","volume":"13","author":[{"given":"Limin","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guofang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,28]]},"reference":[{"issue":"1","key":"1099_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0968-0004(96)20031-3","volume":"22","author":"EA Dennis","year":"1997","unstructured":"Dennis EA: The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem Sci. 1997, 22 (1): 1-2. 10.1016\/S0968-0004(96)20031-3","journal-title":"Trends Biochem Sci"},{"issue":"2\u20133","key":"1099_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S1388-1981(99)00158-4","volume":"1441","author":"ZS Derewenda","year":"1999","unstructured":"Derewenda ZS, Ho YS: PAF-acetylhydrolases. Biochim Biophys Acta. 1999, 1441 (2\u20133): 229-236.","journal-title":"Biochim Biophys Acta"},{"key":"1099_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0090-6980(02)00023-0","volume":"68\u201369","author":"H Arai","year":"2002","unstructured":"Arai H: Platelet-activating factor acetylhydrolase. Prostaglandins Other Lipid Mediat. 2002, 68\u201369: 83-94.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"1","key":"1099_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1056\/NEJMoa070030","volume":"358","author":"P Vadas","year":"2008","unstructured":"Vadas P, Gold M, Perelman B, Liss GM, Lack G, Blyth T, Simons FE, Simons KJ, Cass D, Yeung J: Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med. 2008, 358 (1): 28-35. 10.1056\/NEJMoa070030","journal-title":"N Engl J Med"},{"issue":"3","key":"1099_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/09629359791758","volume":"6","author":"P Vergne","year":"1997","unstructured":"Vergne P, Praloran V, Treves R, Denizot Y: Decreased levels of serum platelet-activating factor acetylhydrolase in patients with rheumatic diseases. Mediators Inflamm. 1997, 6 (3): 241-242. 10.1080\/09629359791758","journal-title":"Mediators Inflamm"},{"issue":"4","key":"1099_CR6","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1097\/01.CCM.0000158519.80090.74","volume":"33","author":"G Nakos","year":"2005","unstructured":"Nakos G, Kitsiouli E, Hatzidaki E, Koulouras V, Touqui L, Lekka ME: Phospholipases A2 and platelet-activating-factor acetylhydrolase in patients with acute respiratory distress syndrome. Crit Care Med. 2005, 33 (4): 772-779. 10.1097\/01.CCM.0000158519.80090.74","journal-title":"Crit Care Med"},{"issue":"3","key":"1099_CR7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1203\/PDR.0b013e3181eb2efe","volume":"68","author":"J Lu","year":"2010","unstructured":"Lu J, Pierce M, Franklin A, Jilling T, Stafforini DM, Caplan M: Dual roles of endogenous platelet-activating factor acetylhydrolase in a murine model of necrotizing enterocolitis. Pediatr Res. 2010, 68 (3): 225-230. 10.1203\/PDR.0b013e3181eb2efe","journal-title":"Pediatr Res"},{"key":"1099_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1476-511X-10-170","volume":"10","author":"IT Silva","year":"2011","unstructured":"Silva IT, Mello AP, Damasceno NR: Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A2 (Lp-PLA2): a review. Lipids Health Dis. 2011, 10: 170- 10.1186\/1476-511X-10-170","journal-title":"Lipids Health Dis"},{"issue":"16","key":"1099_CR9","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJM200010193431603","volume":"343","author":"CJ Packard","year":"2000","unstructured":"Packard CJ, O\u2019Reilly DS, Caslake MJ, McMahon AD, Ford I, Cooney J, Macphee CH, Suckling KE, Krishna M, Wilkinson FE, Rumley A, Lowe GD: Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med. 2000, 343 (16): 1148-1155. 10.1056\/NEJM200010193431603","journal-title":"N Engl J Med"},{"issue":"5","key":"1099_CR10","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.ahj.2006.01.011","volume":"152","author":"HT May","year":"2006","unstructured":"May HT, Horne BD, Anderson JL, Wolfert RL, Muhlestein JB, Renlund DG, Clarke JL, Kolek MJ, Bair TL, Pearson RR, Sudhir K, Carlquist JF: Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death. Am Heart J. 2006, 152 (5): 997-1003. 10.1016\/j.ahj.2006.01.011","journal-title":"Am Heart J"},{"issue":"1","key":"1099_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1386-6346(03)00006-8","volume":"26","author":"T Kamisako","year":"2003","unstructured":"Kamisako T, Takeuchi K, Ito T, Tamaki S, Kosaka T, Adachi Y: Serum platelet-activating factor acetylhydrolase (PAF-AH) activity in patients with hyperbilirubinemic hepatobiliary disease. Hepatol Res. 2003, 26 (1): 23-27. 10.1016\/S1386-6346(03)00006-8","journal-title":"Hepatol Res"},{"issue":"6","key":"1099_CR12","first-page":"324","volume":"8","author":"Chinese Society of Infectious Diseases and Parasitic Diseases","year":"2000","unstructured":"Chinese Society of Infectious Diseases and Parasitic Diseases: Chinese Medical Association: Management scheme of diagnostic and therapy criteria of viral hepatitis [in Chinese]. Chin J Hepatol (Zhonghua Gan Zang Bing Za Zhi). 2000, 8 (6): 324-329.","journal-title":"Chin J Hepatol (Zhonghua Gan Zang Bing Za Zhi)"},{"issue":"8","key":"1099_CR13","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1007\/s10096-011-1538-x","volume":"31","author":"J Yang","year":"2012","unstructured":"Yang J, He J, Cao H, Zhao X, Fu S, Lu H, Chen Y, Pan X, Li L: Correlation between plasma amino acid profiles and the various stages of hepatitis B infection. Eur J Clin Microbiol Infect Dis. 2012, 31 (8): 2045-2052. 10.1007\/s10096-011-1538-x","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"1099_CR14","doi-asserted-by":"publisher","first-page":"739","DOI":"10.4049\/jimmunol.177.1.739","volume":"177","author":"D Xu","year":"2006","unstructured":"Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z, Zhao JM, Zhang B, Shi M, Ding X, Tang Z, Fu YX, Wang FS: Circulating and liver resident CD4\u2009+\u2009CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol. 2006, 177 (1): 739-747. 10.4049\/jimmunol.177.1.739","journal-title":"J Immunol"},{"issue":"9","key":"1099_CR15","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00535-003-1162-3","volume":"38","author":"WM Ke","year":"2003","unstructured":"Ke WM, Ye YN, Huang S: Discriminant function for prognostic indexes and probability of death in chronic severe hepatitis B. J Gastroenterol. 2003, 38 (9): 861-864. 10.1007\/s00535-003-1162-3","journal-title":"J Gastroenterol"},{"issue":"2","key":"1099_CR16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1053\/jhep.2001.22172","volume":"33","author":"PS Kamath","year":"2001","unstructured":"Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D\u2019Amico G, Dickson ER, Kim WR: A model to predict survival in patients with end-stage liver disease. Hepatology. 2001, 33 (2): 464-470. 10.1053\/jhep.2001.22172","journal-title":"Hepatology"},{"issue":"1\u20132","key":"1099_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0009-8981(00)00216-3","volume":"296","author":"T Kosaka","year":"2000","unstructured":"Kosaka T, Yamaguchi M, Soda Y, Kishimoto T, Tago A, Toyosato M, Mizuno K: Spectrophotometric assay for serum platelet-activating factor acetylhydrolase activity. Clin Chim Acta. 2000, 296 (1\u20132): 151-161.","journal-title":"Clin Chim Acta"},{"key":"1099_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1146\/annurev.biochem.69.1.419","volume":"69","author":"SM Prescott","year":"2000","unstructured":"Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM: Platelet-activating factor and related lipid mediators. Annu Rev Biochem. 2000, 69: 419-445. 10.1146\/annurev.biochem.69.1.419","journal-title":"Annu Rev Biochem"},{"issue":"23","key":"1099_CR19","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.3748\/wjg.v12.i23.3695","volume":"12","author":"NP Karidis","year":"2006","unstructured":"Karidis NP, Kouraklis G, Theocharis SE: Platelet-activating factor in liver injury: a relational scope. World J Gastroenterol. 2006, 12 (23): 3695-3706.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1099_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1478-3231.2005.01186.x","volume":"26","author":"AD Grypioti","year":"2006","unstructured":"Grypioti AD, Theocharis SE, Demopoulos CA, Papadopoulou-Daifoti Z, Basayiannis AC, Mykoniatis MG: Effect of platelet-activating factor (PAF) receptor antagonist (BN52021) on acetaminophen-induced acute liver injury and regeneration in rats. Liver Int. 2006, 26 (1): 97-105. 10.1111\/j.1478-3231.2005.01186.x","journal-title":"Liver Int"},{"issue":"9","key":"1099_CR21","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1016\/S0021-9258(18)61335-3","volume":"262","author":"DM Stafforini","year":"1987","unstructured":"Stafforini DM, McIntyre TM, Carter ME, Prescott SM: Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor. J Biol Chem. 1987, 262 (9): 4215-4222.","journal-title":"J Biol Chem"},{"key":"1099_CR22","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/ejlt.200300845","volume":"105","author":"CAKH Demopoulos","year":"2003","unstructured":"Demopoulos CAKH, Antonopoulou S: Platelet Activating Factor. A molecular link between atherosclerosis theories. Eur J Lipid Sci and Technol. 2003, 105: 705-716. 10.1002\/ejlt.200300845.","journal-title":"Eur J Lipid Sci and Technol"},{"issue":"2","key":"1099_CR23","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s11897-013-0131-2","volume":"10","author":"P Detopoulou","year":"2013","unstructured":"Detopoulou P, Nomikos T, Fragopoulou E, Chrysohoou C, Antonopoulou S: Platelet activating factor in heart failure: potential role in disease progression and novel target for therapy. Curr Heart Fail Rep. 2013, 10 (2): 122-129. 10.1007\/s11897-013-0131-2","journal-title":"Curr Heart Fail Rep"},{"issue":"8","key":"1099_CR24","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s00204-005-0651-y","volume":"79","author":"AD Grypioti","year":"2005","unstructured":"Grypioti AD, Theocharis SE, Papadimas GK, Demopoulos CA, Papadopoulou-Daifoti Z, Basayiannis AC, Mykoniatis MG: Platelet-activating factor (PAF) involvement in acetaminophen-induced liver toxicity and regeneration. Arch Toxicol. 2005, 79 (8): 466-474. 10.1007\/s00204-005-0651-y","journal-title":"Arch Toxicol"},{"issue":"10","key":"1099_CR25","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1007\/s10620-006-9728-6","volume":"52","author":"AD Grypioti","year":"2007","unstructured":"Grypioti AD, Kostopanagiotou G, Mykoniatis M: Platelet-activating factor inactivator (rPAF-AH) enhances liver\u2019s recovery after paracetamol intoxication. Dig Dis Sci. 2007, 52 (10): 2580-2590. 10.1007\/s10620-006-9728-6","journal-title":"Dig Dis Sci"},{"issue":"1","key":"1099_CR26","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s10620-006-9363-2","volume":"52","author":"AD Grypioti","year":"2007","unstructured":"Grypioti AD, Mykoniatis M, Demopoulos CA, Kostopanagiotou G: Recombinant platelet-activating factor-acetylhydrolase attenuates paracetamol-induced liver oxidative stress, injury, and regeneration. Dig Dis Sci. 2007, 52 (1): 192-199. 10.1007\/s10620-006-9363-2","journal-title":"Dig Dis Sci"},{"issue":"6","key":"1099_CR27","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3748\/wjg.v8.i6.961","volume":"8","author":"DW Han","year":"2002","unstructured":"Han DW: Intestinal endotoxemia as a pathogenetic mechanism in liver failure. World J Gastroenterol. 2002, 8 (6): 961-965.","journal-title":"World J Gastroenterol"},{"issue":"44","key":"1099_CR28","doi-asserted-by":"publisher","first-page":"27543","DOI":"10.1074\/jbc.272.44.27543","volume":"272","author":"KM Howard","year":"1997","unstructured":"Howard KM, Miller JE, Miwa M, Olson MS: Cell-specific regulation of expression of plasma-type platelet-activating factor acetylhydrolase in the liver. J Biol Chem. 1997, 272 (44): 27543-27548. 10.1074\/jbc.272.44.27543","journal-title":"J Biol Chem"},{"issue":"5 Pt 1","key":"1099_CR29","first-page":"G891","volume":"274","author":"SI Svetlov","year":"1998","unstructured":"Svetlov SI, Howard KM, Debuysere MS, Olson MS: Secretory PAF-acetylhydrolase of the rat hepatobiliary system: characterization and partial purification. Am J Physiol. 1998, 274 (5 Pt 1): G891-G900.","journal-title":"Am J Physiol"},{"issue":"17","key":"1099_CR30","doi-asserted-by":"crossref","first-page":"9682","DOI":"10.1016\/S0021-9258(19)38724-1","volume":"265","author":"DM Stafforini","year":"1990","unstructured":"Stafforini DM, Elstad MR, McIntyre TM, Zimmerman GA, Prescott SM: Human macrophages secret platelet-activating factor acetylhydrolase. J Biol Chem. 1990, 265 (17): 9682-9687.","journal-title":"J Biol Chem"},{"issue":"2","key":"1099_CR31","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1006\/bbrc.1999.1066","volume":"261","author":"K Asano","year":"1999","unstructured":"Asano K, Okamoto S, Fukunaga K, Shiomi T, Mori T, Iwata M, Ikeda Y, Yamaguchi K: Cellular source (s) of platelet-activating-factor acetylhydrolase activity in plasma. Biochem Biophys Res Commun. 1999, 261 (2): 511-514. 10.1006\/bbrc.1999.1066","journal-title":"Biochem Biophys Res Commun"},{"issue":"25","key":"1099_CR32","doi-asserted-by":"crossref","first-page":"16667","DOI":"10.1016\/S0021-9258(18)55353-9","volume":"266","author":"EB Tarbet","year":"1991","unstructured":"Tarbet EB, Stafforini DM, Elstad MR, Zimmerman GA, McIntyre TM, Prescott SM: Liver cells secrete the plasma form of platelet-activating factor acetylhydrolase. J Biol Chem. 1991, 266 (25): 16667-16673.","journal-title":"J Biol Chem"},{"issue":"3","key":"1099_CR33","first-page":"205","volume":"9","author":"CJ Meade","year":"1994","unstructured":"Meade CJ, Birke F, Metcalfe S, Watson C, Jamieson N, Neild G: Serum PAF-acetylhydrolase in severe renal or hepatic disease in man: relationship to circulating levels of PAF and effects of nephrectomy or transplantation. J Lipid Mediat Cell Signal. 1994, 9 (3): 205-215.","journal-title":"J Lipid Mediat Cell Signal"},{"issue":"3","key":"1099_CR34","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1046\/j.1440-1746.2000.02126.x","volume":"15","author":"T Shima","year":"2000","unstructured":"Shima T, Tada H, Morimoto M, Nakagawa Y, Obata H, Sasaki T, Park H, Nakajo S, Nakashima T, Okanoue T, Kashima K: Serum total bile acid level as a sensitive indicator of hepatic histological improvement in chronic hepatitis C patients responding to interferon treatment. J Gastroenterol Hepatol. 2000, 15 (3): 294-299. 10.1046\/j.1440-1746.2000.02126.x","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"1099_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/0005-2760(94)90219-4","volume":"1213","author":"SA Karabina","year":"1994","unstructured":"Karabina SA, Liapikos TA, Grekas G, Goudevenos J, Tselepis AD: Distribution of PAF-acetylhydrolase activity in human plasma low-density lipoprotein subfractions. Biochim Biophys Acta. 1994, 1213 (1): 34-38. 10.1016\/0005-2760(94)90219-4","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"1099_CR36","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1001\/archinte.1997.00440280120012","volume":"157","author":"C Cicognani","year":"1997","unstructured":"Cicognani C, Malavolti M, Morselli-Labate AM, Zamboni L, Sama C, Barbara L: Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch Intern Med. 1997, 157 (7): 792-796. 10.1001\/archinte.1997.00440280120012","journal-title":"Arch Intern Med"},{"key":"1099_CR37","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.11569\/wcjd.v17.i36.3740","volume":"17","author":"K Ma","year":"2009","unstructured":"Ma K, Xu D, Tian DY: Prognostic significance of serum platelet-activating factor in chronic severe hepatitis B. World Chin J Digestol. 2009, 17: 3740-3744.","journal-title":"World Chin J Digestol"},{"issue":"Suppl 1","key":"1099_CR38","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1016\/S1590-8658(07)80016-8","volume":"39","author":"CT Guerra","year":"2007","unstructured":"Guerra CT, Caini P, Giannini C, Giannelli F, Gragnani L, Petrarca A, Solazzo V, Monti M, Laffi G, Zignego AL: Effect of chronic hepatitis C virus infection on inflammatory lipid mediators. Dig Liver Dis. 2007, 39 (Suppl 1): S76-S82.","journal-title":"Dig Liver Dis"},{"issue":"1","key":"1099_CR39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1365-2893.2006.00766.x","volume":"14","author":"P Caini","year":"2007","unstructured":"Caini P, Guerra CT, Giannini C, Giannelli F, Gragnani L, Petrarca A, Solazzo V, Monti M, Laffi G, Zignego AL: Modifications of plasma platelet-activating factor (PAF)-acetylhydrolase\/PAF system activity in patients with chronic hepatitis C virus infection. J Viral Hepat. 2007, 14 (1): 22-28. 10.1111\/j.1365-2893.2006.00766.x.","journal-title":"J Viral Hepat"},{"issue":"4","key":"1099_CR40","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s10620-010-1390-3","volume":"56","author":"MR Al Sibae","year":"2011","unstructured":"Al Sibae MR, Cappell MS: Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS. Dig Dis Sci. 2011, 56 (4): 977-987. 10.1007\/s10620-010-1390-3","journal-title":"Dig Dis Sci"},{"issue":"5","key":"1099_CR41","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/MAT.0b013e3181e6bf13","volume":"56","author":"W Mao","year":"2010","unstructured":"Mao W, Ye B, Lin S, Fu Y, Chen Y: Prediction value of model for end-stage liver disease scoring system on prognosis in the acute on chronic liver failure patients with plasma exchange treatment. ASAIO J. 2010, 56 (5): 475-478. 10.1097\/MAT.0b013e3181e6bf13","journal-title":"ASAIO J"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-511X-13-105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T19:19:17Z","timestamp":1630610357000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/1476-511X-13-105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,28]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1099"],"URL":"https:\/\/doi.org\/10.1186\/1476-511x-13-105","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,28]]},"assertion":[{"value":"7 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"105"}}